20 September 2019 - - The US Food and Drug Administration approved the combination of Keytruda, US-based pharmaceutical company Merck's (NYSE: MRK) anti-PD-1 therapy, plus Lenvima, the orally available kinase inhibitor discovered by Eisai, for t...
20 September 2019 - - Paul A. Meyers, M.D., chief, Pediatric Sarcoma Service and vice chair for Clinical Affairs of Memorial Sloan Kettering Cancer Center, presented a case study of a patient with Ewing sarcoma who achieved a sustained response follo...
20 September 2019 - Life sciences company Elysium Health Inc revealed on Thursday that its New Drug (IND) application has been accepted by the US Food and Drug Administration (FDA) to evaluate the efficacy of BASIS for the prevention of acute kidney ...
20 September 2019 - Portola Pharmaceuticals Inc (Nasdaq: PTLA), a global, commercial-stage biopharmaceutical company, announced yesterday that it has named Ted W Love, MD as a new director.Dr Love has more than 25 years of experience in the discovery...
20 September 2019 - Graybug Vision, a clinical stage pharmaceutical company, has started its phase 2a study with GB-102 in patients with macular oedema derived from diabetic macular oedema or retinal vein occlusion, it was reported yesterday.The prod...